J&J to provide US government with additional 100 million Covid vaccine doses
Raises projected supply of one-dose shot to 200 million
Though difficult to believe, it has been one year since the World Health Organization declared the Covid-19 outbreak a pandemic.
Since then, there has been plenty of progress in the quest to combat the virus. In the past couple of weeks alone, key vaccine-activity developments have surfaced, including the announcement that Johnson & Johnson would be teaming up with Merck to help manufacture the J&J vaccine.
J&J chairman and CEO Alex Gorsky recently visited the White House, where President Biden announced that the US would be purchasing an additional 100 million doses of the company's Covid-19 vaccine. Last August, J&J signed an agreement with the US government to deliver 100 million doses of its vaccine—a commitment, the company says, it is on track to meet.
Newron, Myung In Pharm Form Partnership Centered Around Treating Schizophrenia in South Korea
January 14th 2025The license agreement will feature an upcoming Phase III trial and—depending on results—the development, manufacturing, and commercialization of evenamide as a potential treatment option.
